Minerva
Minerva
Minerva
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7387.508 (Published 01 March 2003) Cite this as: BMJ 2003;326:508Tamoxifen reduces the risk of breast cancer by about 50% in women at high risk. It also protects these women against benign breast disease, according to a new study (Journal of the National Cancer Institute 2003;95:302-7). Women who took tamoxifen in the original breast cancer prevention trial were 28% less likely than controls to get benign breast disease, and 29% less likely than controls to need a breast biopsy during an …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.